PB 75 of 2015
 
National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 6)
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated          29        July 2015
 
 
 
 
 
 
 
 
 
ADRIANA PLATONA
 
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health
 
 
 
 
Part 1         Preliminary
1              Name of Determination
         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 6).
         (2)   This Determination may also be cited as PB 75 of 2015.
2              Commencement
                This Determination commences on 1 August 2015.
3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1             Amendments
 
(Section 3)
 
 
[1]     Schedule 1, after item dealing with Calcium
 
Omit
 
Canagliflozin
 
[2]     Schedule 1, after item dealing with Ciclesonide
 
Omit
 
Cinacalcet
 
 
[3]     Schedule 1, after item dealing with Nystatin
 
Insert
 
Obinutuzumab
 
[4]     Schedule 1, after item dealing with Poly-L-Lactic acid
 
Omit
 
Polythylene glycol 400 with propylene glycol
 
Insert
 
Polyethylene Glycol 400 with Propylene Glycol
 
 
Insert
 
Pomalidomide
 
 
[5]     Schedule 1, after item dealing with Propantheline
 
Omit
 
Propranolol
 
[6]     Schedule 1, after item dealing with Toremifene
 
Insert
 
Trametinib
 
 
[7]     Schedule 1, after item dealing with Varenicline
 
Insert
 
Vedolizumab
 
[8]     Schedule 2, after item dealing with Prochlorperazine
 
Insert
 
Propranolol